disopyramide (Compound)

Synonyms:disopyramide, 3737-09-5, Dicorantil, Isorythm, Lispine, Ritmodan, Rythmodan, Disopiramida, Rythmodan P, Searle 703, Disopyramidum, Ritmilen, Disopyramidum [INN-Latin], Disopiramida [INN-Spanish], Disopyramide Free Base, SC 7031, Dl-disopyramide, SC-7031, (rs)-disopyramide, gamma-Diisopropylamino-alpha-phenyl-alpha-(2-pyridyl)butyramide, Searle-703, alpha-Diisopropylaminoethyl-alpha-phenylpyridine-2-acetamide, 4-[di(propan-2-yl)amino]-2-phenyl-2-pyridin-2-ylbutanamide, H 3292, 1216989-88-6, CHEMBL517, alpha-(2-(Diisopropylamino)ethyl)-alpha-phenyl-2-pyridineacetamide, GFO928U8MQ, 2-Pyridineacetamide, alpha-(2-(bis(1-methylethyl)amino)ethyl)-alpha-phenyl-, CHEBI:4657, DTXSID1045536, 3737-09-5 (free base), 4-(diisopropylamino)-2-phenyl-2-pyridin-2-ylbutanamide, NCGC00015358-18, H-3292, 2-Pyridineacetamide, .alpha.-[2-[bis(1-methylethyl)amino]ethyl]-.alpha.-phenyl-, DTXCID9025536, 4-(diisopropylamino)-2-phenyl-2-(pyridin-2-yl)butanamide, CAS-3737-09-5, Rythmodan P (TN), SR-01000003039, ALPHA-[2-(DIISOPROPYLAMINO)ETHYL]-ALPHA-PHENYL-2-PYRIDINEACETAMIDE, 2-PYRIDINEACETAMIDE, .ALPHA.-(2-(BIS(1-METHYLETHYL)AMINO)ETHYL)-.ALPHA.-PHENYL-, NCGC00016985-01, Prestwick_681, EINECS 223-110-2, MFCD00057366, Norpace (Salt/Mix), Spectrum_001008, Prestwick0_000266, Prestwick1_000266, Prestwick2_000266, Prestwick3_000266, Spectrum2_001033, Spectrum3_000404, Spectrum4_000524, Spectrum5_000943, DISOPYRAMIDE [MI], DISOPYRAMIDE [INN], DISOPYRAMIDE [JAN], UNII-GFO928U8MQ, D 7644, DISOPYRAMIDE [USAN], DISOPYRAMIDE [VANDF], Lopac0_000402, Lopac0_000411, SCHEMBL16153, BSPBio_000112, BSPBio_001928, DISOPYRAMIDE [MART.], KBioGR_001127, KBioSS_001488, MLS002222242, (+/-)-DISOPYRAMIDE, DISOPYRAMIDE [WHO-DD], DivK1c_000489, SPBio_001245, SPBio_002331, BPBio1_000124, GTPL7167, SC 13957 (Salt/Mix), SCHEMBL23931452, KBio1_000489, KBio2_001488, KBio2_004056, KBio2_006624, KBio3_001148, Disopyramide (JP17/USAN/INN), NINDS_000489, HMS1568F14, HMS2095F14, HMS2234G08, HMS3261A06, HMS3369O21, HMS3712F14, HMS3886E08, DISOPYRAMIDE [EP MONOGRAPH], Disopyramide [USAN:INN:BAN:JAN], Disopyramide 1.0 mg/ml in Methanol, Tox21_110727, Tox21_500402, 2-Pyridineacetamide, alpha-(2-(diisopropylamino)ethyl)-alpha-phenyl-, BDBM50028893, NSC791109, s5490, AKOS015894712, Tox21_110727_1, CCG-204495, DB00280, LP00402, NSC-791109, SDCCGSBI-0050388.P006, IDI1_000489, NCGC00015358-04, NCGC00015358-05, NCGC00015358-06, NCGC00015358-08, NCGC00015358-09, NCGC00015358-10, NCGC00015358-11, NCGC00015358-12, NCGC00015358-13, NCGC00015358-14, NCGC00015358-15, NCGC00015358-19, NCGC00015358-24, NCGC00015358-25, NCGC00093829-01, NCGC00093829-02, NCGC00093829-03, NCGC00261087-01, AC-16018, BS-17145, HY-12533, SMR001307254, SBI-0050388.P005, AB00053462, CS-0011990, D2793, EU-0100402, FT-0667714, C06965, D00303, T70845, AB00053462_16, AB00053462_17, Q425120, SR-01000003039-3, 4-Diisopropylamino-2-phenyl-2-(2-pyridyl)-butyramide, BRD-A29734509-001-03-8, BRD-A29734509-011-02-9, BRD-A29734509-011-06-0, SR-01000003039-10, 4-(Diisopropylamino)-2-phenyl-2-(2-pyridinyl)butanamide, 4-(Diisopropylamino)-2-phenyl-2-(2-pyridyl)butyramide, Z1556052559, 4-(Diisopropylamino)-2-phenyl-2-(2-pyridinyl)butanamide #, 4-DIISOPROPYLAMINO-2-PHENYL-2-(2-PYRIDYL)BUTYRAMIDE, Disopyramide, European Pharmacopoeia (EP) Reference Standard, 4-[bis(propan-2-yl)amino]-2-phenyl-2-(pyridin-2-yl)butanamide, .alpha.-(2-(Diisopropylamino)ethyl)-.alpha.-phenyl-2-pyridineacetamide, .gamma.-Diisopropylamino-.alpha.-phenyl-.alpha.-(2-pyridyl)butyramide, 2-Pyridineacetamide, .alpha.-[2-(diisopropylamino)ethyl]-.alpha.-phenyl-, 4-[bis(propan-2-yl)amino]-2-phenyl-2-(pyridin-2-yl)butanimidic acid, alpha-[2-[Bis(1-methylethyl)amino]ethyl]-alpha-phenyl-2-pyridineacetamide, racemic 2-phenyl-2-(2-pyridyl)-4-[N,N-bis(1-methylethyl)amino]butanamide

Pubchem:PUBCHEM:3114

Id:cd3fedc4-13c5-5631-ade0-5b0bae1bc47e

Description:nan